NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch NMTC
See up to 3 months of NMTC. The 7-day demo opens the 1M and 3M ranges and puts NMTC on your watchlist.
Start 7-day demoLatest NMTC insider trades
- David J. Wambeke - OfficerOpen-market purchase$67K
Mark Christianson - OfficerOpen-market sale$32K
About NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
NEUROONE MEDICAL TECHNOLOGIES Corp is an SEC registrant, filing under CIK 0001500198, classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
NMTC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 33,333 | $67K |
| Grant or award | 6 | 178,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NMTC insider transactions (Form 4)
3938 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David J. Wambeke - Officer | Open-market purchase | Common Stock | 33,333 | $2.01 footnote F1 | $67K | |
| David J. Wambeke - Officer | Grant or award | Option to Purchase Common Stock | 35,000 | $0.00 | - | |
| ||||||
| Emily J. Johns - Officer | Grant or award | Option to Purchase Common Stock | 12,500 | $0.00 | - | |
| Christopher Volker - Officer | Grant or award | Option to Purchase Common Stock | 35,000 | $0.00 | - | |
| Mark Christianson - Officer | Grant or award | Option to Purchase Common Stock | 12,500 | $0.00 | - | |
| Steve Mertens - Officer | Grant or award | Option to Purchase Common Stock | 15,000 | $0.00 | - | |
| David A. Rosa - Officer | Grant or award | Option to Purchase Common Stock | 68,000 | $0.00 | - | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 10,000 | $3.18 | $32K | |
| Jason Richard Mills - Director | Grant or award | Common Stock | 41,929 footnote F1 | $0.00 | - | |
| Jason Richard Mills - Director | Grant or award | Option to Purchase Common Stock | 26,036 | $0.00 | - | |
| ||||||
 Jeffrey S. Mathiesen - Director | Grant or award | Common Stock | 41,929 footnote F1 | $0.00 | - | |
| Jeffrey S. Mathiesen - Director | Grant or award | Option to Purchase Common Stock | 26,036 | $0.00 | - | |
| ||||||
| Paul Buckman - Director | Grant or award | Common Stock | 41,929 footnote F1 | $0.00 | - | |
| Paul Buckman - Director | Grant or award | Option to Purchase Common Stock | 26,036 | $0.00 | - | |
| ||||||
| Edward Andrle - Director | Grant or award | Common Stock | 41,929 footnote F1 | $0.00 | - | |
| Edward Andrle - Director | Grant or award | Option to Purchase Common Stock | 26,036 | $0.00 | - | |
| ||||||
| Mark Christianson - Officer | Open-market sale | Common Stock | 15,363 | $0.74 | $11K | |
| Mark Christianson - Officer | Tax withholding / forfeiture | Common Stock | 253 | $0.78 | $197 | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 906 | $0.78 | $704 | |
| David A. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 2,458 | $0.78 | $2K | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 817 | $0.80 | $654 | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 100 | $0.80 | $80 | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 11,611 | $0.80 footnote F1 | $9K | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 2,109 | $0.80 footnote F2 | $2K | |
| ||||||
| David J. Wambeke - Officer | Open-market purchase | Common Stock | 1,000,000 | $0.67 | $670K | |
| David J. Wambeke - Officer | Grant or award | Option to Purchase Common Stock | 500,000 | $0.00 | - | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 7,376 | $0.68 | $5K | |
| Mark Christianson - Officer | Tax withholding / forfeiture | Common Stock | 1,812 | $0.68 | $1K | |
| David A. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 71,325 | $0.68 | $49K | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 906 | $0.89 | $805 | |
| Mark Christianson - Officer | Tax withholding / forfeiture | Common Stock | 253 | $0.89 | $225 | |
| David A. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 2,458 | $0.89 | $2K | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 30,000 | $0.74 | $22K | |
| Mark Christianson - Officer | Tax withholding / forfeiture | Common Stock | 253 | $0.68 | $172 | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 906 | $0.68 | $614 | |
| David A. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 2,458 | $0.68 | $2K | |
| Jeffrey S. Mathiesen - Director | Grant or award | Option to Purchase Common Stock | 50,000 | $0.00 | - | |
| Paul Buckman - Director | Grant or award | Option to Purchase Common Stock | 50,000 | $0.00 | - | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 252 | $0.62 | $157 | |
Item 2.02, 8.01, 9.01
Item 8.01, 9.01
Item 2.02, 9.01
Item 8.01, 9.01
Recent NMTC Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
NMTC insider trading FAQ
What is the latest insider trade for NMTC?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) had 6 insider filings in the last 90 days, with the most recent on 2026-09-08. The full record for NMTC runs to 38 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NMTC stock?
1 insider purchase of NMTC was filed in the last 90 days, totaling $67K.
How many insiders are selling NMTC stock?
No insider sales of NMTC were filed in the last 90 days. 7 sales are on record for this company.
Where can I see NMTC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NMTC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David J. Wambeke view on EDGAR
- - Emily J. Johns view on EDGAR
- - Christopher Volker view on EDGAR
- - Mark Christianson view on EDGAR
- - Steve Mertens view on EDGAR
- - David A. Rosa view on EDGAR
- - Mark Christianson view on EDGAR
- - Jason Richard Mills view on EDGAR
- - Jeffrey S. Mathiesen view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NMTC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NMTC with a 7-day demo
- NMTC on your watchlist
- Every NMTC Form 4 filing on record
- Up to 3 months of NMTC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
